J. Mel Sorensen
2019
In 2019, J. Mel Sorensen earned a total compensation of $2.5M as President and Chief Executive Officer at Galera Therapeutics, a 373% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $139,729 |
|---|---|
| Option Awards | $1,893,771 |
| Salary | $431,602 |
| Total | $2,465,102 |
Sorensen received $1.9M in option awards, accounting for 77% of the total pay in 2019.
Sorensen also received $139.7K in non-equity incentive plan and $431.6K in salary.
Rankings
In 2019, J. Mel Sorensen's compensation ranked 4,925th out of 13,971 executives tracked by ExecPay. In other words, Sorensen earned more than 64.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,925 out of 13,971 | 65th |
Division Manufacturing | 1,832 out of 5,701 | 68th |
Major group Chemicals And Allied Products | 642 out of 2,200 | 71st |
Industry group Drugs | 542 out of 1,886 | 71st |
Industry Pharmaceutical Preparations | 405 out of 1,398 | 71st |
Source: SEC filing on April 27, 2020.
Sorensen's colleagues
We found two more compensation records of executives who worked with J. Mel Sorensen at Galera Therapeutics in 2019.
News
Galera Therapeutics CEO J Sorensen's 2023 pay slips 8% to $1.3M
January 24, 2025
Galera Therapeutics CEO J Sorensen's 2022 pay falls 46% to $1.4M
April 27, 2023
Galera Therapeutics CEO J Sorensen's 2021 pay slips 14% to $2.5M
April 28, 2022
Galera Therapeutics CEO J Sorensen's 2019 pay jumps 373% to $2.5M
April 27, 2020